Central Nervous System
Oragenics acquires neurological assets from Odyssey Health
Oragenics has concluded the previously announced acquisition of assets focusing on neurological drug therapies and technologies from Odyssey Health. The…
FDA warns of rare hypersensitivity reaction due to antiseizure drugs
The US Food and Drug Administration (FDA) has issued a warning that the two antiseizure medications, namely levetiracetam and clobazam,…
BMS agrees to acquire Karuna Therapeutics for $14bn
Bristol Myers Squibb (BMS) has signed a definitive agreement for the acquisition of all outstanding shares of common stock of…
Long-lasting oral therapy developer Lyndra secures a $101m Series E
Lyndra Therapeutics has raised $101m in a Series E financing round as the company looks to advance its long-lasting oral…
Knight secures rights for ADHD treatment Qelbree from Supernus
Knight Therapeutics has signed an exclusive licence agreement with Supernus Pharmaceuticals for the attention-deficit hyperactivity disorder (ADHD) treatment Qelbree (viloxazine)…
Neurogene concludes merger deal with Neoleukin Therapeutics
Neurogene has concluded its merger deal with biopharmaceutical company Neoleukin Therapeutics to become a combined company focusing on the development…
INmune’s Alzheimer’s trial still on clinical hold, FDA requests more data
The US Food and Drug Administration (FDA) has notified Florida-based INmune Bio that its Phase II clinical trial investigating XPro…
Organon and Lilly sign deal to supply two migraine drugs in Europe
Organon has signed a commercialisation agreement with Eli Lilly and Company for two migraine medicines, Emgality (galcanezumab) and REYVOW (lasmiditan),…
InvaGen recalls seizure treatment due to leaking sachets
Cipla subsidiary InvaGen Pharmaceuticals has issued a voluntary recall of a single lot of its refractory complex partial seizure (CPS)…
Vanda acquires rights to Actelion’s multiple sclerosis drug
Vanda Pharmaceuticals has acquired rights to Johnson & Johnson (J&J) company Actelion Pharmaceuticals’ (Janssen) Ponvory (ponesimod) to treat adults with…
